跳至主要内容
临床试验/IRCT20120227009157N7
IRCT20120227009157N7尚未招募早期 1 期

Effect of nano formulation of saffron crocin on depression symptoms and cognitive impairment in patients with multiple sclerosis

Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
早期 1 期
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Willingness to participate in the study•
  • Age range between 18 to 60 years old
  • Diagnosis of relapse remission multiple sclerosis according to the McDonalds 2010 criteria and taking B-interferon as treatment
  • Diagnosis of mild to moderate according to DSM V(Diagnostic and Statistical Manual of Mental Disorders, 5th edition) by a neurologist and Beck Depression Inventory (BDI-II) (score from 11 to 20)
  • EDSS lower than 5.5

排除标准

  • Pregnancy (or having a planned pregnancy) or Lactation
  • Allergy or sensibility to the drugs at the beginning of their treatments
  • History of allergy or sensibility to Saffron or its components
  • Receiving IVIG during the last six months of treatment
  • Increase of liver enzymes three times more than normal value
  • Stop taking drugs for more than forth months

研究者

相似试验